Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

The AQUABEAM India study evaluating the Aquablation system for benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AQUABEAM Aquablation System

Snippet

Sponsor: PROCEPT BioRobotics | Conditions: Benign Prostatic Hyperplasia | NA | Status: COMPLETED